Highvista Strategies LLC / OCUL
Highvista Strategies LLC’s Ocular Therapeutix Inc Position
Does Highvista Strategies LLC own Ocular Therapeutix Inc (OCUL)? Yes — 441.6K shares worth $4M (+1.03% of its 13F portfolio) as of Q1 2026, up from 344.1K shares the prior filed quarter.
Position Value
$4M
Q1 2026
Shares
441.6K
% of Portfolio
+1.03%
Quarters Held
11
currently held
Position History OCUL
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 441.6K | $4M | +1.03% |
| Q4 2025 | 344.1K | $4M | +1.08% |
| Q3 2025 | 106.6K | $1M | +0.31% |
| Q2 2025 | 88.9K | $824,769 | +0.30% |
| Q1 2025 | 85.2K | $624,817 | +0.24% |
| Q4 2024 | 85.2K | $727,958 | +0.27% |
| Q3 2024 | 65.0K | $565,735 | +0.20% |
| Q2 2024 | 61.9K | $423,116 | +0.15% |
| Q4 2021 | 59.0K | $411,000 | +0.33% |
| Q3 2021 | 69.1K | $691,000 | +0.46% |
| Q2 2021 | 61.6K | $875,000 | +0.62% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Highvista Strategies LLC’s full portfolio or all institutional holders of OCUL.